| Bell Trace Health & Living | |
|
725 N Bell Trace Cir, Bloomington, IN 47408-4408 | |
| (812) 323-2858 | |
| (812) 323-2854 |
| Full Name | Bell Trace Health & Living |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 725 N Bell Trace Cir, Bloomington, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992956536 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 22002301A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Bell Trace Health & Living 725 N Bell Trace Cir, Bloomington, IN 47408-4408 Ph: (812) 323-2858 | Bell Trace Health & Living 725 N Bell Trace Cir, Bloomington, IN 47408-4408 Ph: (812) 323-2858 |
News Archive
When bees sting, they pump into their victims a peptide toxin called melittin that destroys cell membranes. Now, by encapsulating this extremely potent molecule within a nanoparticle, researchers at the Washington University School of Medicine in St. Louis have created a potential new type of anticancer therapy with the potential to target a wide range of tumors. This work was reported in the Journal of Clinical Investigation.
The U.S. Food and Drug Administration today approved Vistogard (uridine triacetate) for the emergency treatment of adults and children who receive an overdose of the cancer treatment fluorouracil or capecitabine, or who develop certain severe or life-threatening toxicities within four days of receiving these cancer treatments.
Viamet Pharmaceuticals Inc. today reported positive interim results from an ongoing Phase 2 study of VT-1161, the Company's novel oral antifungal compound, in patients with moderate to severe acute vulvovaginal candidiasis (AVVC). This study is intended as a precursor to a Phase 2b study in patients with recurrent vulvovaginal candidiasis (RVVC).
Perrigo Company today announced that the United States Court of Appeals for the fourth Circuit has affirmed an earlier decision that Mead Johnson had engaged in false advertising resulting in an injunction prohibiting Mead Johnson from making similar claims and awarding damages in favor of PBM.
› Verified 1 days ago
Daniel Fogerty, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 725 N Bell Trace Cir, Bloomington, IN 47408 Phone: 812-323-2858 | |
Ms. Bettina R Manuel, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3021 E Tapps Turn, Bloomington, IN 47401 Phone: 812-322-7771 Fax: 812-855-5561 | |
Ms. Melanie Jill Mazur, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 S Jordan Ave, Bloomington, IN 47405 Phone: 812-855-3605 | |
Lillian Martindale, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 443 S Landmark Ave, Bloomington, IN 47403 Phone: 812-676-7000 | |
Bell Trace Health And Living Center Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 725 N Bell Trace Cir, Bloomington, IN 47408 Phone: 812-323-2858 Fax: 812-323-2854 | |
Doreen Dotlich Devitt, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1100 S Curry Pike, Bloomington, IN 47403 Phone: 812-330-6700 | |
Chelsea Silverman, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2455 N Tamarack Trl, Bloomington, IN 47408 Phone: 812-336-7060 |